T1	Observation 2 18	previous history
T2	Condition 22 33	intolerance
T3	Drug 41 51	study drug
T4	Drug 55 72	related compounds
*	OR T3 T4
T5	Scope 41 72	study drug or related compounds
R1	Has_scope Arg1:T2 Arg2:T5	
R2	Has_temporal Arg1:T2 Arg2:T1	
T6	Condition 99 109	alcoholism
T7	Condition 111 121	drug abuse
T8	Condition 123 134;169 177	psychiatric problems
T9	Condition 136 149;169 177	psychological problems
T10	Condition 159 177	emotional problems
*	OR T8 T9 T10
T11	Condition 226 238	Sleep apnoea
T12	Condition 240 277	Chronic obstructive pulmonary disease
T13	Measurement 279 282	BMI
T14	Value 283 287	= 35
T15	Measurement 291 297	weight
T16	Value 298 305	< 50 kg
R3	Has_value Arg1:T13 Arg2:T14	
R4	Has_value Arg1:T15 Arg2:T16	
*	OR T13 T15
T17	Measurement 307 311	SpO2
T18	Value 312 318	< 90 %
R5	Has_value Arg1:T17 Arg2:T18	
T19	Measurement 332 344	drug therapy
T20	Temporal 320 331	Concomitant
T21	Observation 372 388;403 413	enzyme induction of CYP 3A4
T22	Observation 372 378;392 413	enzyme inhibition of CYP 3A4
*	OR T21 T22
R6	Has_temporal Arg1:T19 Arg2:T20	
T23	Scope 372 413	enzyme induction or inhibition of CYP 3A4
R7	Has_scope Arg1:T19 Arg2:T23	
T24	Condition 416 425	Pregnancy
T25	Condition 429 436	nursing
*	OR T24 T25
